A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer
Clinical trial NCT01237678 · TERMINATED
Trial details
- NCT number
- NCT01237678
- Sponsor
- ImmunoGen, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2015-05-01
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.